Compare Duolingo Inc (DUOL) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duolingo Inc vs Merck & Co., Inc. — how do they compare? Duolingo Inc trades at $128.96 (market cap $5.98B), while Merck & Co., Inc. trades at $123.5 (market cap $298.31B). The key difference: Merck & Co., Inc. is far larger — about 49.9× Duolingo Inc's market cap, and Merck & Co., Inc. pays a 2.82% dividend while Duolingo Inc pays none. Which is the better fit depends on your goals.
| DUOL | MRK | |
|---|---|---|
Market Cap | $5.98B | $298.31B |
Sector | Technology | Health |
52-Week High | $390.84 | $129.52 |
52-Week Low | $90.03 | $77.60 |
Enterprise Value | $4.82B | $341.72B |
Dividend Yield | — | 2.82% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
